Jochen Brumm
-
- Diabetes Treatment and Management 3
- Surgery top 5%
- Cancer Research top 5%
- Immunology top 10%
- Biosimilars and Bioanalytical Methods 5
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Air Quality and Health Impacts 3
- Climate Change and Health Impacts 3
-
- CAR-T cell therapy research 3
-
- Bioinformatics and Genomic Networks 3
- Protein purification and stability 3
- Co-authors
- David KallendPhilip J. BarterEran LeitersdorfR. Scott WrightIngar HolmeAnders OlssonBernard ChaitmanChristie M. Ballantyne
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Jochen Brumm
25 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Endocrinology, Diabetes and Metabolism 829
- Surgery 1.1k
- Cancer Research 317
- Cardiology and Cardiovascular Medicine 379
- Immunology 225
Countries citing papers authored by Jochen Brumm
This map shows the geographic impact of Jochen Brumm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Brumm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Brumm more than expected).
Fields of papers citing papers by Jochen Brumm
This network shows the impact of papers produced by Jochen Brumm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Brumm. The network helps show where Jochen Brumm may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jochen Brumm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 16 | |
| 10 | 2021 | 22 | |
| 11 | 2021 | 30 | |
| 12 | 2020 | 6 | |
| 13 | 2019 | 2 | |
| 14 | Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndromebreakdown → | 2012 | 1465 |
| 15 | 2008 | 138 | |
| 16 | 2008 | 1 | |
| 17 | 2008 | 10 | |
| 18 | 2008 | 25 | |
| 19 | 2005 | 21 | |
| 20 | 2002 | 39 |
About Jochen Brumm
Jochen Brumm is a scholar working on Biophysics, Immunology and Health, Toxicology and Mutagenesis, having authored 29 papers that have together received 2.1k indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Air Quality and Health Impacts (3 papers), CAR-T cell therapy research (3 papers), Climate Change and Health Impacts (3 papers), Bioinformatics and Genomic Networks (3 papers), Protein purification and stability (3 papers) and Diabetes Treatment and Management (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (829 citations), Surgery (1.1k citations) and Cancer Research (317 citations). Jochen Brumm has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include David Kallend, Philip J. Barter, Eran Leitersdorf, R. Scott Wright, Ingar Holme, Anders Olsson, Bernard Chaitman, Christie M. Ballantyne, Markus Abt and John J.V. McMurray. Their work appears in journals such as mAbs, Bioanalysis, PLoS ONE, Journal of Exposure Science & Environmental Epidemiology and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.